English
French
German
Italian
Russian
Spanish
Portuguese
Dutch
Greek
Japanese
Korean
Home ProductsHuman Growth Hormone

Recombinant Human Erythropoietin Injection Epo Prefilled Syringe 3000 iu

Send Me The Latest Product Alerts
(No SPAM - We would not sell or share your e-mail address.)

Recombinant Human Erythropoietin Injection Epo Prefilled Syringe 3000 iu

Good Quality Recombinant Human Erythropoietin Injection Epo Prefilled Syringe 3000 iu Sales

Large Image :  Recombinant Human Erythropoietin Injection Epo Prefilled Syringe 3000 iu

Marvel Pharma Inc.

Verified Supplier

China

Business type: Manufacturer, Distributor/Wholesaler, Exporter, Trading Company, Seller

Telephone : 86-0745-2722878

22nd Floor, New Times Plaza, Hecheng, Huaihua 418000, Hunan CHINA

Product Details:

Place of Origin: China
Brand Name: Sihuan EPO
Certification: GMP
Model Number: EPO 3000iu / syringe

Payment & Shipping Terms:

Minimum Order Quantity: 1 kit
Price: Negotiable
Packaging Details: Discreet packing
Delivery Time: 24 hrs
Payment Terms: Western Union, MoneyGram
Supply Ability: 100000kits/month
Detailed Product Description
Product Name: Erythropoietin Injection Epo Pre Filled Syringe Specification: 3000iu/syringe, 5 Syringes/kit, 15000 Iu/kit
Usage: Used For Bodybuilding EPO Injection Price: Negotiable
EPO Injection Dosage: Around 50 To 100 Units/kg Per Kilogram Of Body Weight EPO Injection Half Life: 4-13 Hours
EPO Injection Side Effects: Severe Pelvic Pain; Swelling Of The Hands Or Legs; Stomach Pain And Swelling; Shortness Of Breath; Weight Gain; Diarrhea; Nausea Or Vomiting; Or. Urinating Less Than Normal.

Recombinant human erythropoietin injection epo pre filled syringe 3000iu syringe for sale

 

Quick Detail:

 

Brand Name:EPO(Erythropoietin)    Model Number:3000iu/vial*5vials

 

Description:

 

It also has other known biological functions. For example, erythropoietin plays an important role in the brain's response to neuronal injury.Erythropoietin, or its alternative erythropoetin or EPO, is a glycoprotein hormone that controls erythropoiesis, or red blood cell production. It is a cytokine for erythrocyte (red blood cell) precursors in the bone marrow.

 

Applications:

 

Also called hematopoietin or hemopoietin, it is produced by the peritubular capillary endothelial cells in the kidney, and is the hormone that regulates red blood cell production. It also has other known biological functions. For example, erythropoietin plays an important role in the brain's response to neuronal injury. EPO is also involved in the wound healing process.

 

Specifications:

 

When exogenous EPO is used as a performance-enhancing drug, it is classified as an erythropoiesis-stimulating agent (ESA). Exogenous EPO can often be detected in blood, due to slight difference from the endogenous protein, for example in features of posttranslational modification.

 

Competitive Advantage:

 

We are special and leading in developing, manufacturing and marketing pharmaceuticals and health-care products.

We are located in China Taizhou New and High Technology Development Area. As based on high-efficient Research & Development Center.

We are the largest China rHGH/Somatropin/Recombinant Human Growth Hormone.

HGH is also known as human growth hormone. Study found that human growth hormone secretion with age and tends to reduce the amount. 12 years old -30 years old was reduced by approximately 15%, while the 60-year-old not to half ago. HGH secretion daily 20-year-olds peaked about 500 micrograms to 300 micrograms of only 60 years old, 80 years old, only 25 micrograms. Generally considered to start after age 30 is aging, HGH increases with age and decay, and therefore is a human growth hormone supplements can enhance immune system function to achieve the purpose of a key longevity.
 

We are special and leading in developing, manufacturing and marketing pharmaceuticals and health-care products.

We are located in China Taizhou New and High Technology Development Area. As based on high-efficient Research & Development Center.

We are the largest China rHGH/Somatropin/Recombinant Human Growth Hormone

Trust decision development, loyalty to win trust, the ability to create value, the industrious and returns and competition to the competition

Recombinant Human Erythropoietin Injection Epo Prefilled Syringe 3000 iu

 

What is erythropoietin?

Erythropoietin (also known as EPO) is a growth factor that stimulates the production of red blood cells. Most of the cells in the blood are red blood cells, whose main function is to carry oxygen throughout the body.

Erythropoietin is used to treat anemia resulting from kidney failure or cancer treatment. It is considered to be an alternative to blood transfusions.

There are several different types of erythropoietins. Procrit® and Epogen® are two brands of epoetin alfa. Aranesp® (darbepoetin alfa) is another type of erythropoietin. The major difference between Procrit/Epogen and Aranesp is that Aranesp is given less often than Procrit. Otherwise, all three agents work equally well in the treatment of anemia.

How is anemia treated in multiple myeloma?

Anemia is typically defined as having a hemoglobin (Hb) level below normal. Hemoglobin is the substance found within red blood cells that carries oxygen from the lungs to the tissues in the body. Normal hemoglobin levels are:

  • 12 to 16 g/dL for women
  • 14 to 18 g/dL for men

Severity of Anemia Hemoglobin Level (g/dL)

  • Mild (10 or more)
  • Moderate (8-9.9)
  • Severe (6.5-7.9)
  • Life-Threatening (Less than 6.5)

Treatment of anemia in patients with myeloma is complex, because both the disease itself and the treatments for myeloma may cause anemia. For this reason, a step-wise approach is recommended:

  • Treatment with myeloma drugs to control the underlying cancer. Patients who respond to myeloma treatment, especially those who achieve a complete remission, may have an improvement in their anemia.
  • Check and treat other causes of anemia such as low levels of iron or other nutrients (folate, vitamin B12), internal bleeding or kidney problems.
  • If anemia is still moderate (but causing symptoms) or severe then blood transfusions or erythropoietin therapy should be used.

Erythropoietin is an alternative to blood transfusions in patients with moderate to severe anemia, resulting from their myeloma treatment. If anemia is severe and requires immediate treatment, patients should receive a blood transfusion. A blood transfusion may also be necessary in cases where a patient does not respond to erythropoietin therapy.

In some cases, erythropoietin therapy may also be considered for mild anemia (Hb = 10-11 g/dL), such as:

  • Elderly patients with heart and lung problems
  • Patients with arthrosclerosis
  • Patients who have angina or chest pains

Significant symptoms impacting patient’s quality of life such as: substantially reduced ability to take care of themselves, reduced energy and ability to exercise (e.g., walking, climbing stairs).
Treating anemia allows more oxygen to circulate throughout the body, which can result in more energy, reduced fatigue, and the restored ability to be active. Several clinical trials have shown that treating anemia associated with cancer treatment with erythropoietin:

Significantly improved quality of life, including the ability to perform usual daily activities and to work. Reduced the need for transfusions in patients receiving chemotherapy by about half. May reduce the number of days cancer patients with anemia spend in the hospital.

What are the possible side effects?

Erythropoietic agents are generally well tolerated. However, recent studies have shown that these drugs have been associated with an increased risk of blood clots. Factors that can increase the risk of developing blood clots include:

  • A history of blood clots
  • Recent surgery
  • Prolonged periods of bed rest or limited activity
  • Treatment with some common myeloma drugs including Revlimid, Thalomid, dexamethasone, Adriamycin and Doxil.

Preventive treatment with a blood thinner (such as heparin) may be considered for high-risk patients.

Erythropoietin Safety Concern: Do erythropoietins decrease cancer survival?

A number of studies in several types of cancers have shown that patients taking erythropoietin did not live as long as other patients. Most of these studies were not conducted in multiple myeloma. Further, erythropoietin was used in a way that is different from how it is typically used in practice today. In contrast, an analysis of studies where erythropoietin was used appropriately did not show any impact on survival.

Due to these possible safety problems, erythropoietin drugs are now used more cautiously.

You and your doctor will discuss the benefits and risks of erythropoietin therapy in your individual case.

How are erythropoietin drugs given?

Erythropoietin therapy is given as an injection under the skin at home by patients or caregivers.

The most common initial dosing schedules for the various types of erythropoietins are listed below:

  • Procrit/Epogen: 150 units/kg three times a week or 40,000 units/kg once weekly
  • Aranesp: 2.25mcg/kg once a week or 500mcg every three 3 weeks

Your dose may be changed based upon how you respond to therapy. In addition, depending on your individual situation, your doctor may recommend an alternate dosing schedule.

Supplemental iron may be given in addition to erythropoietin therapy.

How is the effectiveness of erythropoietin determined?

Blood tests are used to monitor erythropoietin therapy. The effectiveness of therapy is measured by the increase in hemoglobin and a related test called hematocrit (the number and size of red blood cells) following therapy.

It takes some time for the body to produce new blood cells, so the effect of erythropoietic agents may not be seen for 2 to 6 weeks. The amount of time it takes, and the dose needed varies from patient to patient.

Overall, about 60% to 70% of cancer patients receiving cancer treatment respond to erythropoietic agents. An early hemoglobin response to therapy (≥1 g/dL rise after 4 weeks of therapy) in patients with treatment-related anemia is often associated with reduced transfusion requirements, higher hemoglobin response rates, and improved quality of life. Having adequate iron levels may also improve responses to erythropoietin therapy.

Patients less likely to respond to erythropoietic therapy include those with reduced bone marrow function at the start of erythropoietic treatment, those with heavy transfusion needs as well as patients with persistent infections.

How are erythropoietin drugs used with high dose chemotherapy and autologous stem cell transplant?

Anemia is a common side effect of high-dose chemotherapy and autologous stem cell transplant due to the chemotherapy’s effect on the blood-producing cells in the bone marrow. Administration of erythropoietin immediately after transplant has been less effective in treating this type of anemia. However, with increasing time, erythropoietin re-gains its effectiveness.

 

Quality grade  pharmacy epo 
epo full name erythropoietin
epo half life 4-13 hours
epo dosage

around 50 to 100 Units/kg per kilogram of body weight

 
 

Recombinant Human Erythropoietin Injection Epo Prefilled Syringe 3000 iu


 

EPO injection Reviews from forums, such as eroids, musclegurus, muscletalk, steroidology, uk-muscle forums, including HMG injection reviews 2011, EPO injection reviews 2012, EPO injection reviews 2013, EPO injection reviews 2014, EPO injection reviews 2015 .

.cn , www.hygetropin.

What else HGH & Steroids & peptides we are selling?

 

Human Growth Hormone List:
 
Hygetropin 200iu/kit Riptropin 100iu/kit Ansomone 100iu/kit Jintropin 100iu/kit Kigtropin 100iu/kit
Hygetropin 100iu/kit Angtropin 100iu/kit Taitropin 100iu/kit Getropin 100iu/kit Blue Top HGH 100iu/kit
Igtropin 1mg/kit IGF-1 LR3 1mg/kit IGF-1 LR3 10mg/kit HCG 25000iu/kit EPO 15000iu/kit
HMG 375iu/kit Red Top HGH 100iu/kit Yellow Top HGH 100iu/kit Haratropin 100iu/kit Igetropin 100iu/kit
 
PolyPeptides Hormone List: 
 
GHRP-6 5mg/vial GHRP-2 5mg/vial Ipamorelin 5mg/vial Ipamorelin 5mg/vial
CJC-1295 with DAC 2mg/vial CJC-1295 W/O DAC 2mg/vial MT-2 10mg/vial MT-1 10mg/vial
PEG-MGF (IGF 1EC)2mg/vial  PEG-MGF 2mg/vial HGH FAG 176-191 5mg/vial  FAG 176-195 2mg/vial
Hexarelin 5mg/vial Hexarelin 2mg/vial Thymosin bate 4 2mg/vial Sermorelin 2mg/vial
PT-141 10mg/vial DSIP 5mg/vial DSIP 1mg/vial Selank 5mg/vial
Selank 2mg/vial Oxytocin 2mg/vial Gonadorelin 2mg/vial Triptorelin 100mcg/vial
GHRP 2mg/vial Tesamorelin 2mg/vial BPC 157 5mg/vial Follistatin 1mg/vial
 
Centrino Labs Injectables List: 
 
Testoviron 250mg/ml Prop 100 100mg/ml Depot CYP 250 250mg/ml Sustanon 250 250mg/ml
Deca 200 200mg/ml Winstrol 50 50mg/ml Tren 75 75mg/ml Tren 100 100mg/ml
Equipoise 200mg/ml Bold 200 200mg/ml Masteron 100mg/ml Primobolan 100mg/ml

Contact Details
China Chemical Online Marketplace

Send your inquiry directly to us (0 / 3000)